Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-18 Kelsey Stephen Michael See Remarks Sale 10b5-1 −2,123 $31.58 $67K 270,909
2024-03-18 Horn Margaret A Chief Operating Officer Sale 10b5-1 −2,914 $31.58 $92K 139,553
2024-03-18 GOLDSMITH MARK A See Remarks Sale 10b5-1 −5,788 $31.58 $183K 460,379
2024-03-18 Anders Jack Chief Financial Officer Sale 10b5-1 −1,261 $31.58 $40K 101,959
2024-03-12 Horn Margaret A Chief Operating Officer Option exercise 10b5-1 +7,936 $4.09 $32K 150,403
2024-03-12 Horn Margaret A Chief Operating Officer Sale 10b5-1 −7,936 $34.07 $270K 142,467
2024-03-12 Horn Margaret A Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −7,936 44,631
2024-03-11 Horn Margaret A Chief Operating Officer Option exercise 10b5-1 +15,735 $4.09 $64K 158,202
2024-03-11 Horn Margaret A Chief Operating Officer Sale 10b5-1 −15,735 $34.02 $535K 142,467
2024-03-11 Horn Margaret A Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −15,735 52,567
2024-03-01 Horn Margaret A Chief Operating Officer Grant or award +41,000 142,467
2024-03-01 Horn Margaret A Chief Operating Officer Grant or award · Stock Option (Right to Buy) +143,500 143,500
2024-03-01 GOLDSMITH MARK A See Remarks Grant or award −90,000 466,167
2024-03-01 GOLDSMITH MARK A See Remarks Grant or award · Stock Option (Right to Buy) +314,000 314,000
2024-03-01 Cislini Jeff General Counsel Grant or award +21,000 57,126
2024-03-01 Cislini Jeff General Counsel Grant or award · Stock Option (Right to Buy) +73,500 73,500
2024-03-01 Kelsey Stephen Michael See Remarks Grant or award +51,400 273,032
2024-03-01 Kelsey Stephen Michael See Remarks Grant or award · Stock Option (Right to Buy) +179,900 179,900
2024-03-01 Anders Jack Chief Financial Officer Grant or award +26,400 103,220
2024-03-01 Anders Jack Chief Financial Officer Grant or award · Stock Option (Right to Buy) +92,400 92,400

Page 27 of 29 · 569 trades